Clinical trial
Phase I Trial of huA33 Plus Chemotherapy in Patients With Metastatic Colorectal…
NCT00199797 · Ludwig Institute for Cancer Research, Other · Completed
Key facts
| NCT number | NCT00199797 |
|---|---|
| Title | Phase I Trial of huA33 Plus Chemotherapy in Patients With Metastatic Colorectal Cancer |
| Official title | Phase I Trial of huA33 Plus 5-fluorouracil (5-FU), Leucovorin and Oxaliplatin in Patients With Metastatic Colorectal Cancer |
| Lead sponsor | Ludwig Institute for Cancer Research, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | Oxaliplatin, 5-Fluorouracil, Leucovorin, huA33 |
| Enrollment | 20 |
| Start date | Apr 18, 2005 |
| Primary completion | Nov 8, 2006 |
| Completion | Apr 1, 2016 |
| First posted | Sep 20, 2005 |
| Last update posted | Oct 10, 2022 |
| Countries | Germany, Switzerland |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: